Antibody responses to the blood group antigen D in SCID mice reconstituted with human blood mononuclear cells
- PMID: 1634246
- PMCID: PMC1421550
Antibody responses to the blood group antigen D in SCID mice reconstituted with human blood mononuclear cells
Abstract
Mice with severe combined immunodeficiency (SCID) were reconstituted with peripheral blood mononuclear cells (PBMC) obtained from D-negative individuals who had been sensitized to D-positive erythrocytes. Anti-D was spontaneously secreted in mice reconstituted with PBMC obtained from donors within 14 days of re-immunization with D-positive erythrocytes, but was not detected in murine plasma when mice were reconstituted with PBMC obtained from the same donors many years after sensitization, even though anti-D was still present in the serum of these donors. In the murine plasma the anti-D titres were not related to the total human immunoglobulin concentrations. SCID mice reconstituted with PBMC from some donors immune to D-positive erythrocytes (but not immunized within 34 days of donating the sample) made a recall response to the D antigen, which in some cases was maintained for at least 84 days. Depletion of adherent cells from the reconstituting PBMC reduced the total concentration of human IgG obtained. These results show that SCID mice reconstituted with human PBMC (Hu PBMC-SCID) can make a recall response to the D antigen which cannot be attributed to non-specific polyclonal B-lymphocyte activation, and that efficient antigen processing and presentation of the integral erythrocyte membrane D polypeptide occurs in the Hu PBMC-SCID model.
Similar articles
-
NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant.Transpl Immunol. 2003 Oct-Nov;12(1):9-18. doi: 10.1016/S0966-3274(03)00060-1. Transpl Immunol. 2003. PMID: 14551028
-
Immunoglobulin production in severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood mononuclear cells.Eur J Immunol. 1992 Mar;22(3):823-8. doi: 10.1002/eji.1830220329. Eur J Immunol. 1992. PMID: 1312475
-
Antibody responses to Toxoplasma gondii antigen in human peripheral blood lymphocyte-reconstituted severe-combined immunodeficient mice reproduce the immunological status of the lymphocyte donor.Eur J Immunol. 1995 May;25(5):1426-30. doi: 10.1002/eji.1830250543. Eur J Immunol. 1995. PMID: 7774646
-
Autoimmunity versus allo- and xeno-reactivity in SCID mice.Int Rev Immunol. 1994;11(4):283-93. doi: 10.3109/08830189409051175. Int Rev Immunol. 1994. PMID: 7806942 Review.
-
Humoral immunity in scid mice reconstituted with cells from immunoglobulin-deficient or normal humans.Immunol Rev. 1991 Dec;124:113-38. doi: 10.1111/j.1600-065x.1991.tb00619.x. Immunol Rev. 1991. PMID: 1804777 Review. No abstract available.
Cited by
-
Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse.Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9146-50. doi: 10.1073/pnas.91.19.9146. Proc Natl Acad Sci U S A. 1994. PMID: 8090783 Free PMC article.
-
Human platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model.Clin Exp Immunol. 2014 Apr;176(1):23-36. doi: 10.1111/cei.12242. Clin Exp Immunol. 2014. PMID: 24261689 Free PMC article.
-
Control of human thyroid autoantibody production in SCID mice.Clin Exp Immunol. 1993 Mar;91(3):390-6. doi: 10.1111/j.1365-2249.1993.tb05914.x. Clin Exp Immunol. 1993. PMID: 8443961 Free PMC article.
-
Reduction of human anti-tetanus toxoid antibody in hu-PBL-SCID mice by immunodominant peptides of tetanus toxoid.Clin Exp Immunol. 2004 Aug;137(2):245-52. doi: 10.1111/j.1365-2249.2004.02521.x. Clin Exp Immunol. 2004. PMID: 15270840 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources